Johnson & Johnson officer Elizabeth Forminard filed a Form 144 notice of proposed sale of 13,072 shares of Johnson & Johnson common stock, with an approximate sale date of November 12, 2026, executed through Fidelity Brokerage Services LLC.

Key Highlights

  • Seller: Elizabeth Forminard, identified as an officer of Johnson & Johnson.
  • Shares proposed for sale: 13,072 shares of common stock.
  • Aggregate market value: $3,717,546.08, as stated in the filing.
  • Acquisition method: The shares were acquired through a stock option exercise from the issuer on November 12, 2026, with payment made in cash.
  • Broker: Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI 02917.
  • Total shares outstanding: 2,407,310,266 shares of common stock, according to the filing.
  • Prior sales: The filing reports nothing to report for securities sold during the past three months.

Johnson & Johnson Officer Forminard Proposes Sale Following Stock Option Exercise

According to the Form 144 filed with the U.S. Securities and Exchange Commission, Elizabeth Forminard, an officer of Johnson & Johnson (NYSE:JNJ), provided notice of a proposed sale of 13,072 shares of the company's common stock. The filing lists an approximate sale date of November 12, 2026, and identifies Fidelity Brokerage Services LLC as the executing broker. The aggregate market value of the shares proposed for sale is stated as $3,717,546.08.

The filing discloses that the 13,072 shares were acquired on November 12, 2026, through a stock option exercise from the issuer, with cash listed as the nature of payment. No prior sales of Johnson & Johnson securities were reported by Forminard during the three months preceding the filing date. The filing was signed by Wade Moss as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Elizabeth Forminard.

Johnson & Johnson is listed on the NYSE and is headquartered at One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933. The filing carries SEC File Number 001-03215 and was submitted as a live filing on November 12, 2026. The total number of shares of common stock outstanding is listed in the filing as 2,407,310,266.

What Was Disclosed

A Form 144 notice was filed on November 12, 2026, by Johnson & Johnson officer Elizabeth Forminard, disclosing a proposed sale of 13,072 shares of common stock acquired via stock option exercise, with an aggregate market value of $3,717,546.08.